Evidence map›Paper›PMID 36661800›Full record

ArticleGels (Basel, Switzerland)2022

The Methyl Functionality of Monolithic Silica Xerogels Synthesized via the Co-Gelation Approach Combined with Surface Silylation.

Selay Sert Çok, Fatoş Koç, Zoltán Dudás, Nilay Gizli

Open access · goldAbstract read
In one paragraph

Article in Gels (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Selay Sert ÇokChemical Engineering Department, Ege University, İzmir 35100, Turkey.ORCID 0000-0001-7595-2151
Fatoş KoçChemical Engineering Department, Ege University, İzmir 35100, Turkey.ORCID 0000-0002-2996-110X
Zoltán DudásCentre for Energy Research, Neutron Spectroscopy Department, 1121 Budapest, Hungary.
Nilay GizliChemical Engineering Department, Ege University, İzmir 35100, Turkey.ORCID 0000-0002-7591-1365
Ege University · TRHUN-REN Centre for Energy Research · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present research aims to investigate the chemical and morphological properties of the methylated silica xerogels produced via the co-gelation approach combined with surface silylation. In the sol−gel synthesis, methyltrimethoxysilane (MTMS) and tetraethylorthosilicate (TEOS) were utilized as silica precursors and trimethylchlorosilane (TMCS) served as a silylating agent. Structural changes were observed depending on the MTMS/TEOS molar ratio and on the post-synthesis-performed surface silylation of the xerogels. Post-synthesis silylation plays a critical role in the exchanging of the surface silanols with methyl groups, preserving the monolithic form. The morphological and structural changes were followed by SEM, 29Si-MAS-NMR, FTIR spectroscopy, nitrogen porosimetry, and contact angle measurements. The results have shown significant structural variations depending especially on the MTMS content. With an increasing MTMS content, the morphology of the samples has changed from a micro/mesoporous texture to a meso/macroporous texture. A higher degree of methyl substitution has been achieved for the silylated samples both confirmed by the FTIR and 29Si-NMR results. On the other hand, only the samples with a high MTMS content could preserve their structural integrity after evaporative drying, and all have exhibited a high degree of hydrophobicity with θ > 140°.

Indexed as

co-gelationsilylationxerogels

Identifiers

PMID36661800
PMCPMC9857546
OpenAlexW4313473239

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.